A previous study assessing the safety of intracerebroventricular catheter implantation for GDNF delivery in PD reported several adverse events, including paraesthesia, nausea, weight loss, and asymptomatic hyponatremia, without significant improvement in symptoms [69]. This evidence concerns the gene GDNF and Parkinson disease.